Suppr超能文献

μ-、δ-和κ-阿片受体以及α2A肾上腺素能受体在潜在致敏过程中对痛觉过敏的持续抑制作用:组成性活性的作用

Sustained Suppression of Hyperalgesia during Latent Sensitization by μ-, δ-, and κ-opioid receptors and α2A Adrenergic Receptors: Role of Constitutive Activity.

作者信息

Walwyn Wendy M, Chen Wenling, Kim Hyeyoung, Minasyan Ani, Ennes Helena S, McRoberts James A, Marvizón Juan Carlos G

机构信息

Department of Psychiatry and Biobehavioral Sciences and.

Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California 90095, and Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, California 90073.

出版信息

J Neurosci. 2016 Jan 6;36(1):204-21. doi: 10.1523/JNEUROSCI.1751-15.2016.

Abstract

UNLABELLED

Many chronic pain disorders alternate between bouts of pain and periods of remission. The latent sensitization model reproduces this in rodents by showing that the apparent recovery ("remission") from inflammatory or neuropathic pain can be reversed by opioid antagonists. Therefore, this remission represents an opioid receptor-mediated suppression of a sustained hyperalgesic state. To identify the receptors involved, we induced latent sensitization in mice and rats by injecting complete Freund's adjuvant (CFA) in the hindpaw. In WT mice, responses to mechanical stimulation returned to baseline 3 weeks after CFA. In μ-opioid receptor (MOR) knock-out (KO) mice, responses did not return to baseline but partially recovered from peak hyperalgesia. Antagonists of α2A-adrenergic and δ-opioid receptors reinstated hyperalgesia in WT mice and abolished the partial recovery from hyperalgesia in MOR KO mice. In rats, antagonists of α2A adrenergic and μ-, δ-, and κ-opioid receptors reinstated hyperalgesia during remission from CFA-induced hyperalgesia. Therefore, these four receptors suppress hyperalgesia in latent sensitization. We further demonstrated that suppression of hyperalgesia by MORs was due to their constitutive activity because of the following: (1) CFA-induced hyperalgesia was reinstated by the MOR inverse agonist naltrexone (NTX), but not by its neutral antagonist 6β-naltrexol; (2) pro-enkephalin, pro-opiomelanocortin, and pro-dynorphin KO mice showed recovery from hyperalgesia and reinstatement by NTX; (3) there was no MOR internalization during remission; (4) MORs immunoprecipitated from the spinal cord during remission had increased Ser(375) phosphorylation; and (5) electrophysiology recordings from dorsal root ganglion neurons collected during remission showed constitutive MOR inhibition of calcium channels.

SIGNIFICANCE STATEMENT

Chronic pain causes extreme suffering to millions of people, but its mechanisms remain to be unraveled. Latent sensitization is a phenomenon studied in rodents that has many key features of chronic pain: it is initiated by a variety of noxious stimuli, has indefinite duration, and pain appears in episodes that can be triggered by stress. Here, we show that, during latent sensitization, there is a sustained state of pain hypersensitivity that is continuously suppressed by the activation of μ-, δ-, and κ-opioid receptors and by adrenergic α2A receptors in the spinal cord. Furthermore, we show that the activation of μ-opioid receptors is not due to the release of endogenous opioids, but rather to its ligand-independent constitutive activity.

摘要

未标注

许多慢性疼痛疾病在疼痛发作期和缓解期之间交替。潜在致敏模型在啮齿动物中再现了这一现象,表明炎性或神经性疼痛的明显恢复(“缓解”)可被阿片类拮抗剂逆转。因此,这种缓解代表了阿片受体介导的对持续痛觉过敏状态的抑制。为了确定相关受体,我们通过在后爪注射完全弗氏佐剂(CFA)在小鼠和大鼠中诱导潜在致敏。在野生型小鼠中,对机械刺激的反应在CFA注射3周后恢复到基线水平。在μ-阿片受体(MOR)基因敲除(KO)小鼠中,反应未恢复到基线水平,但从痛觉过敏峰值部分恢复。α2A-肾上腺素能和δ-阿片受体拮抗剂在野生型小鼠中恢复了痛觉过敏,并消除了MOR KO小鼠中痛觉过敏的部分恢复。在大鼠中,α2A肾上腺素能以及μ-、δ-和κ-阿片受体拮抗剂在CFA诱导的痛觉过敏缓解期间恢复了痛觉过敏。因此,这四种受体在潜在致敏中抑制痛觉过敏。我们进一步证明,MOR对痛觉过敏的抑制是由于其组成性活性,原因如下:(1)CFA诱导的痛觉过敏可被MOR反向激动剂纳曲酮(NTX)恢复,但不能被其中性拮抗剂6β-纳曲醇恢复;(2)脑啡肽原、阿片促黑皮质素原和强啡肽原基因敲除小鼠显示痛觉过敏恢复并被NTX恢复;(3)缓解期间没有MOR内化;(4)缓解期间从脊髓免疫沉淀的MOR具有增加的Ser(375)磷酸化;(5)缓解期间从背根神经节神经元收集的电生理记录显示MOR对钙通道的组成性抑制。

意义声明

慢性疼痛给数百万人带来极大痛苦,但其机制仍有待阐明。潜在致敏是在啮齿动物中研究的一种现象,具有慢性疼痛的许多关键特征:它由多种有害刺激引发,持续时间不定,且疼痛以可由压力触发的发作形式出现。在这里,我们表明,在潜在致敏期间,存在一种持续的疼痛超敏状态,该状态通过脊髓中μ-、δ-和κ-阿片受体以及肾上腺素能α2A受体的激活而持续受到抑制。此外,我们表明μ-阿片受体的激活不是由于内源性阿片类物质的释放,而是由于其配体非依赖性组成性活性。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验